RTW — RTW Biotech Opportunities Cashflow Statement
0.000.00%
Last trade - 00:00- $654.30m
- $808.87m
- $34.57m
Annual cashflow statement for RTW Biotech Opportunities, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -64.3 | -39.4 | 83.2 | 34.2 | 245 |
| Non-Cash Items | 54.3 | 31.3 | -94.1 | -86.9 | -211 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -34.8 | 18.5 | 44.5 | -71.6 | 70.8 |
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -44.9 | 10.4 | 33.5 | -124 | 105 |
| Financing Cash Flow Items | -4.97 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 39.1 | 0 | -2.09 | 97.1 | -12.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5.78 | 10.4 | 31.4 | -27.3 | 92.6 |